Lehrte/Ahlten, Germany

Ulf Preuschoff


 


Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 96(Granted Patents)


Location History:

  • Laatzen, DE (1989 - 1994)
  • Uelzen/Oldenstadt, DE (1999)
  • Ahlten, DE (2000)
  • Uelzen, DE (1993 - 2005)
  • Lehrte/Ahlten, DE (2004 - 2007)
  • Hannover, DE (2007)
  • Isernhagen N.B., DE (2010)

Company Filing History:


Years Active: 1989-2010

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Ulf Preuschoff: Pioneering Innovations and Groundbreaking Patents

Introduction:

Throughout his illustrious career, Ulf Preuschoff has made significant contributions in the fields of technology and engineering, garnering recognition and acclaim for his remarkable milestones. Hailing from Lehrte/Ahlten, Germany, Preuschoff has acquired an impressive portfolio of 16 patents, further solidifying his status as a forefront innovator. This article aims to shed light on his latest patents, career highlights, and notable collaborations that have shaped his remarkable journey.

Latest Patents:

Ulf Preuschoff's most recent patents reflect his innovative approach and involvement in the pharmaceutical industry. One notable patent involves 1-amidomethylcarbonyl-piperidine compounds, methods, and intermediate products for their production, as well as pharmaceutical formulations containing these compounds. This invention explores the potential therapeutic applications of these compounds.

Another groundbreaking patent focuses on 4-substituted 1-amidomethylcarbonyl-piperidine compounds, which exhibit motilin-agonistic properties and their acid addition salts. The patent encompasses pharmaceutical compositions incorporating these compounds, as well as processes and intermediate products for their preparation. Furthermore, it highlights the methods of treatment utilizing these compounds, offering new possibilities in the field of pharmacology.

Method of preparing pharmaceutical compositions:

Preuschoff's expertise extends beyond drug development, as evidenced by his patent for a method of preparing pharmaceutical compositions. This method involves the discovery of compounds suitable for treating and/or preventing obesity by inhibiting de novo lipogenesis in mammals and/or humans. The patent also emphasizes the use of compounds that are capable of inhibiting de novo lipogenesis without significant effects on the central nervous system (CNS). This innovation presents new avenues for addressing obesity and its associated complications.

Career Highlights:

Ulf Preuschoff's notable career has seen him contribute to renowned companies in the pharmaceutical industry. He has lent his expertise to Solvay Pharmaceuticals, GmbH, and Kali-Chemie Pharma GmbH. By collaborating with these organizations, Preuschoff has played an instrumental role in shaping the development of innovative pharmaceutical solutions.

Collaborations:

Throughout his professional journey, Preuschoff has collaborated with esteemed colleagues, including Samuel David and Jochen Antel. These collaborations have provided valuable partnerships, fostering a culture of innovation and enabling the exchange of knowledge and expertise.

Conclusion:

Ulf Preuschoff's remarkable career as an innovative figure in technology and engineering has left an indelible mark on the field of pharmaceuticals. With an impressive portfolio of patents and pioneering contributions to drug development, Preuschoff's work continues to shape advancements within the industry. His collaborations and partnerships further exemplify his commitment to fostering innovation and pushing the boundaries of scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…